— Know what they know.
Not Investment Advice
Also trades as: OABIW (NASDAQ) · $vol 0M

OABI NASDAQ

OmniAb, Inc.
1W: -1.7% 1M: +0.0% 3M: +134.0% YTD: +145.2% 1Y: +188.1% 3Y: -5.9% 5Y: -53.6%
$4.96
+0.35 (+7.59%)
After Hours: $4.75 (-0.21, -4.33%)
Weekly Expected Move ±8.8%
$4 $4 $5 $5 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 54 · $670.2M mcap · 119M float · 1.11% daily turnover · Short 40% of daily vol
Credit Risk of going bust: lower than 56% of companies Debt: 2.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.6%), OmniAb, Inc. would be worth roughly what it owes.
Total debt $18.9M against a stock market value of $670.2M.
Distance to default 5.73 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $9.5M (short-term plus half of long-term), stock volatility 71.9%; Altman Z'' 7.26. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$301M -7.6% ▼
5Y CAGR: +0.4%
Total Liabilities
$34M -10.7% ▼
5Y CAGR: -10.8%
Shareholders Equity
$267M -7.2% ▼
5Y CAGR: +2.5%
Cash & Investments
$54M -9.1% ▼
Total Debt
$20M -12.2% ▼
5Y CAGR: +51.0%
Net Debt
-$5M -17.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$0$33M$16M$28M$26M
Short-Term Investments$0$55M$71M$32M$29M
Cash & ST Investments$0$88M$87M$59M$54M
Net Receivables$21M$30M$4M$5M$7M
Inventory$0$0$0$0$0
Other Current Assets$1M$6M$4M$3M$4M
Total Current Assets$23M$125M$95M$68M$65M
Property, Plant & Equip.$20M$41M$38M$33M$25M
Goodwill & Intangibles$260M$251M$239M$222M$209M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$1M$4M$3M$2M$1M
Total Non-Current Assets$282M$296M$280M$257M$236M
Total Assets$304M$421M$375M$326M$301M
— Liabilities —
Accounts Payable$3M$3M$4M$2M$2M
Short-Term Debt$0$0$0$0$4M
Deferred Revenue$11M$8M$7M$2M$3M
Other Current Liabilities$5M$8M$8M$7M$7M
Total Current Liabilities$21M$26M$23M$15M$16M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$5M$4M$3M$1M$393K
Total Non-Current Liabilities$50M$54M$38M$23M$18M
Total Liabilities$70M$80M$61M$38M$34M
— Equity —
Common Stock$0$12K$12K$12K$14K
Retained Earnings$0$11M-$39M-$101M-$166M
Accumulated OCI$0$9K$50K$27K$12K
Total Stockholders Equity$234M$341M$315M$288M$267M
Total Liabilities & Equity$304M$421M$375M$326M$301M
— Key Metrics —
Total Debt$14M$26M$26M$23M$20M
Net Debt$14M-$8M$9M-$4M-$5M
Total Investments$0$55M$71M$32M$29M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms